The qualification file is closed. Particle size distribution, specific surface area, phase composition, cytocompatibility — every number inside spec, every method referenced, signatures on the last page. The material is approved.
Then it goes to sterilisation, because it has to. And sterilisation sits in most process documents as a utility step: a box, a cycle time, a validated load. Not a place where the material changes.
Two powders, one cycle
In 2012, Santos and colleagues published a study in the Journal of the Royal Society Interface that put that assumption on the bench. They took two hydroxyapatite nanoparticle preparations — one made by wet chemical synthesis at 37 °C, one by hydrothermal synthesis at 180 °C — and ran both through a standard autoclave cycle at 120 °C for 20 minutes.
The hydrothermally synthesised particles came through largely intact.
The wet-chemical particles did not. Their specific surface area fell from 171.0 m²/g to 22.3 m²/g. The authors put it plainly: “sterilization is seen to modify markedly the shape, size and aggregation state of WCS nanoparticles.”
Roughly seven-eighths of the available surface, gone in twenty minutes — in a step that appears on no certificate of analysis, applied to a material that had already passed its specification.
The comparison is the useful part. The same cycle, run on two hydroxyapatites, produced one unchanged material and one substantially different one. Autoclaving does not simply damage hydroxyapatite. What it does depends on how the material was made.
The same question, at ceramic scale
That finding does not stay confined to nanopowders. In 2016, Li, Guo, Xiao, Yuan, Fan and Zhang, working at Sichuan University, reported in the Journal of Materials Science: Materials in Medicine on steam sterilisation of porous calcium phosphate bioceramics — β-tricalcium phosphate, biphasic calcium phosphate and hydroxyapatite — autoclaved at 121 °C for 40 minutes.
Three materials, three different outcomes. For β-TCP, steam sterilisation had “no obvious effects on the phase composition, thermal stability, pH value and dissolubility”, though morphology and mechanical strength did shift. For biphasic calcium phosphate, it caused “significant changes of the morphology, phase composition, pH value and dissolubility”. And hydroxyapatite showed increased dissolubility and mechanical strength, a drop in the pH of the immersed solution, and partial oriented growth of its crystals.
Their conclusion is a procurement instruction dressed as a materials finding: “the steam sterilization can result in different influences on the physicochemical properties of β-TCP, BCP and HA porous bioceramics, thus the application of the steam sterilization on the three kinds of Ca-P porous bioceramics should be considered carefully.”
Which material did you actually approve?
So there are two materials in every one of these projects. There is the one described on the certificate — measured at the supplier, before shipping, before the cycle. And there is the one that reaches the patient or the consumer, measured by nobody.
Closing that gap is not expensive. It is one round of the same characterisation, run on post-sterilisation material, once, so that the delta is known instead of assumed.
But knowing the delta only helps if the delta holds. A sterilisation cycle is reproducible; a material is only reproducible if its synthesis route is. The gap between those two nanopowders is what a change in preparation looks like from the far side of an autoclave — which is why lot-to-lot consistency upstream is what makes any downstream step predictable at all.
Sources
Santos C, Gomes PS, Duarte JA, Franke RP, Almeida MM, Costa MEV, Fernandes MH. “Relevance of the sterilization-induced effects on the properties of different hydroxyapatite nanoparticles and assessment of the osteoblastic cell response.” Journal of the Royal Society Interface, 2012 (open access) — pmc.ncbi.nlm.nih.gov/articles/PMC3481584. Li X, Guo B, Xiao Y, Yuan T, Fan Y, Zhang X. “Influences of the steam sterilization on the properties of calcium phosphate porous bioceramics.” Journal of Materials Science: Materials in Medicine, 2016 — pubmed.ncbi.nlm.nih.gov/26610928.